Corona Remedies Ltd PE Ratio

Corona Remedies PE Ratio

Image

Corona Remedies Ltd

NSE: CORONA

PE

60

Last updated on: Jan 30, 2026

Key Highlights

  • The P/E Ratio of Corona Remedies Ltd is 60 as of 30 Jan 9.00 AM .
  • The P/E Ratio of Corona Remedies Ltd changed from 0 on March 2023 to 0 on March 2025 . This represents a CAGR of 0.0% over 3 years.
  • The Latest Trading Price of Corona Remedies Ltd is ₹ 1469 as of 29 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.3 in 5 years. This represents a CAGR of 5.60%.
  • The PE Ratio of Automobile industry is 21.6. The PE Ratio of Finance industry is 19.0. The PE Ratio of IT - Software industry is 27.7. The PE Ratio of Pharmaceuticals industry is 32.3. The PE Ratio of Retail industry is 123.5. The PE Ratio of Textiles industry is 54.9 in 2025.

Historical P/E Ratio of Corona Remedies Ltd

No data available

Company Fundamentals for Corona Remedies Ltd

Image

Corona Remedies Ltd

NSE: CORONA

Share Price

₹ 1469.95

21.35 (1.47%)

stock direction

Last updated on: Jan 29, 2026

Market Price of Corona Remedies Ltd

1M

1Y

3Y

5Y

Monitoring Corona Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 Jan 20261469.95
28 Jan 20261448.6
27 Jan 20261418.6
23 Jan 20261395.6
22 Jan 20261385.25
21 Jan 20261387.3
20 Jan 20261459.25
19 Jan 20261504.4
16 Jan 20261500.7
14 Jan 20261474.25

SWOT Analysis Of Corona Remedies Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Corona Remedies Ltd

Asset Value vs Market Value of Corona Remedies Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Corona Remedies Ltd8990
Sun Pharmaceutical Industries Ltd381326
Divis Laboratories Ltd160299
Torrent Pharmaceuticals Ltd132821
Cipla Ltd106655
Dr Reddys Laboratories Ltd100861

PE Ratio of Corona Remedies Ltd Explained

8990

Market cap

171

Earnings

60.0X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Corona Remedies Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Corona Remedies Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Corona Remedies Ltd

No data available

* All values are in %

About Corona Remedies Ltd

  • Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli.
  • Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'.
  • A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat).
  • The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005.

Corona Remedies Ltd News Hub

Shares of Corona Remedies list in B group

The equity shares of Corona Remedies (Scrip Code: 544644) are listed effective 15 December 2025 and

Read more

15 Dec 25

Corona Remedies Q2 PAT climbs 22% YoY to Rs 52 cr

Profit before tax (PBT) increased 21.67% year on year (YoY) to Rs 69.78 crore in Q2 FY26. Earnings B

Read more

03 Jan 26

Corona Remedies gains as Q2 PAT climbs 22% YoY to Rs 52 cr

Profit before tax (PBT) increased 21.67% year on year (YoY) to Rs 69.78 crore in Q2 FY26. Earnings B

Read more

05 Jan 26

Corona Remedies spurts on market debut

The stock was listed at Rs 1,452, exhibiting a premium of 36.72% to the issue price. So far, the sto

Read more

15 Dec 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Corona Remedies Ltd

What is the current PE Ratio of Corona Remedies Ltd?

The Current PE Ratio of Corona Remedies Ltd is 59.95 as on 30 Jan 2026.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 32.3 as on 30 Jan 2026.

What was the PE Ratio of Corona Remedies Ltd last year?

The PE Ratio of Corona Remedies Ltd was 0.0 last year, now the PE ratio is 59.95, showing a year-on-year growth of -%.

What does the PE Ratio of Corona Remedies Ltd indicate about its stock?

The PE Ratio of Corona Remedies Ltd is 59.95. This ratio indicates that investors are willing to pay 59.95 times the earnings per share for each share of Corona Remedies Ltd.

What is the PE Ratio Growth of Corona Remedies Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Corona Remedies Ltd grew by -% whereas, the EPS ratio grew by 13.2.

How does the PE ratio of Corona Remedies Ltd compare to industry peers?

The PE ratio of Corona Remedies Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Corona Remedies Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Corona Remedies Ltd PE Ratio.

What factors influence the PE ratio of Corona Remedies Ltd PE Ratio?

The PE ratio of Corona Remedies Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Corona Remedies Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Corona Remedies Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Corona Remedies Ltd PE Ratio?

You can check the latest PE ratio of Corona Remedies Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Corona Remedies Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Corona Remedies Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Corona Remedies Ltd PE Ratio predict future stock performance?

While the Corona Remedies Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions